CN1426790A - Forest frog oil soft capsule - Google Patents
Forest frog oil soft capsule Download PDFInfo
- Publication number
- CN1426790A CN1426790A CN01138864A CN01138864A CN1426790A CN 1426790 A CN1426790 A CN 1426790A CN 01138864 A CN01138864 A CN 01138864A CN 01138864 A CN01138864 A CN 01138864A CN 1426790 A CN1426790 A CN 1426790A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- frog oil
- forest frog
- oil soft
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 9
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 241000191896 Rana sylvatica Species 0.000 claims description 9
- 210000003101 oviduct Anatomy 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 241001122767 Theaceae Species 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 229940089020 evening primrose oil Drugs 0.000 abstract 1
- 239000010475 evening primrose oil Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 230000033228 biological regulation Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000269436 Ranidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003172 anti-dna Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- -1 hydroxyl hydrogen Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A softgel of forest frog fat for delaying senility and regulating blood-fat is prepared from evening primrose oil, forest frog fat, VE and tea polyphenol through scientific compounding. It has high mutritive value.
Description
Technical field: the present invention relates to a kind of nutrient and healthcare products, particularly relate to Oviductus Ranae and Radix Oenotherae erythrosepalae
The Wood frog oil soft capsule of wet goods mixed preparing.
Background technology; Wood frog is commonly called as Oviductus Ranae, is a ground medical value, nutritive value, social valency
Value and aspect such as ecological benefits all have the amphibian Ranidae of important economic implications
Animal, its dry fallopian tube---Oviductus Ranae is a kind of of Northeast China special product
The famous and precious dietetic therapy Chinese medicine of famous China and foreign countries is called " soft Huang by reputation on the international market
Gold ".Chinese medicine and pharmacy thinks that Oviductus Ranae has: enriching yin and nourishing kidney, tonifying deficiency.With
Soreness of the waist and knees, dysphoria with feverish sensation in the chest palms and soles due to the deficiency of the kidney yin, after being ill, puerperal is weak etc.
Yet the said goods people directly eat or take with dry wood frog oil vacuole water,
Have that mouthfeel is poor, unsaturated fatty acid wherein is easily oxidized, easily become sour, with
The time, store inconvenience.
Technology contents: the objective of the invention is to overcome above-mentioned weak point, provide a kind of prescription reasonable,
Easily processing, it is good to take mouthfeel, is convenient to the Wood frog oil soft capsule prescription of absorption of human body.In order to achieve the above object, the technical solution used in the present invention is: Radix Oenotherae erythrosepalae oil 40%～80% Oviductus Ranae 10%～40% vitamin E 5%～10% tea polyphenols 5%～10%
Specific embodiments: following the embodiment of the invention is explained in detail: example 1:
Radix Oenotherae erythrosepalae oil 40g
Oviductus Ranae 40g
Vitamin E 10g
Tea polyphenols 10g example 2:
Radix Oenotherae erythrosepalae oil 80g
Oviductus Ranae 10g
Vitamin E 5g
Tea polyphenols 5g example 3:
Radix Oenotherae erythrosepalae oil 50g
Oviductus Ranae 30g
Vitamin E 10g
Tea polyphenols 10g
Contain a large amount of unsaturated fatty acids in the Wood frog oil soft capsule primary raw material Oviductus Ranae serum total cholesterol, triglyceride concentration are descended, high density lipoprotein raises; Effectively blood lipid regulation improves blood viscosity, reduces thrombosis, recovers vessel wall elasticity.Estradiol, progesterone and hormones be with human body in the identical natural hormone of hormones that produces, energy endocrine regulation system, enhance metabolism, human body immunity improving power, for the middle aged and aged women before and after the menopause, play a big part at aspects such as endocrine regulation system, defying age, strong physique; And its most outstanding be that contained 50% above protein and 40% above aminoacid can make muscle more solid, eliminate because of protein deficient cause wan and sallow, strengthen the elasticity of skin, promote the growth promoter of body, nutrition apace, moist cell.Thereby performance is tired, senile-resistant efficacy.The natural oil antioxidant of institute's adapted in this product---the very low Reducing agent of tea polyphenols one class oxidation-reduction potential has active hydroxyl hydrogen, and excessive combined with radical in hydrogen proton and the body can be provided, and at the elimination activity oxygen-derived free radicals, shows special function.Experimental result proof tea polyphenols has the obvious suppression effect to the DNA chain interruption of hydrogen peroxide-induced, shows that tea polyphenols has the effect of anti-DNA oxidative damage; Outside inferior, aspect blood lipid regulation, play very big effect, on the one hand can obviously reduce serum cholesterol, LDL content and raise HDL contents, and TC, LDL had tangible dose-effect relationship; Promote lipoid substance from feces, to discharge on the other hand, can prevent and treat the effect that atherosclerosis has fat-reducing again.But cooperate also potentiation with vitamin C and vitamin E.
Another composition vitamin E in the Wood frog oil soft capsule can reduce the existence of free radical and increasing of peroxyester matter, can prevent that brain cell is aging, promotes brain cell activity, the generation of slow down aging disease and development.As everyone knows, the people can secondaryly give birth to " active oxygen " when utilizing oxygen, become oxygen poison-free radical, the infringement organism.Free radical can impel fatty over oxidation, cell membrane and cell interior structure are damaged, be known many person in middle and old age's diseases, as the inducement of ischemia, arteriosclerosis, nephritis, hepatic insufficiency, cancer, diabetes, cataract, rheumatism and various inflammation etc.Vitamin E has very strong oxidation resistance, can stop cellular oxidation damage, delaying human body cell chromosome fission process, keep cell function complete, prolong cell survival, delaying human body caducity.Can also eliminate the aged pigment lipofuscin in the tissue, reduce cholesterolemia concentration, suppress arteriosclerotic effect, also have the protective hair tubule, microcirculation improvement and skin elasticity, prevention cataract etc.
In sum, Wood frog oil soft capsule proportioning science, the effect uniqueness, each component can strengthen mutual curative effect again in the synergistic while, is blood lipid regulation, slow down aging best product.
Claims (1)
1, a kind of prescription of Wood frog oil soft capsule is characterized in that: following each components based on weight percentage: Radix Oenotherae erythrosepalae oil 40%～80% Oviductus Ranae 10%～40% vitamin E 5%～10% tea polyphenols 5%～10%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011388641A CN1248597C (en) | 2001-12-21 | 2001-12-21 | Forest frog oil soft capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011388641A CN1248597C (en) | 2001-12-21 | 2001-12-21 | Forest frog oil soft capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1426790A true CN1426790A (en) | 2003-07-02 |
| CN1248597C CN1248597C (en) | 2006-04-05 |
Family
ID=4674816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011388641A Expired - Fee Related CN1248597C (en) | 2001-12-21 | 2001-12-21 | Forest frog oil soft capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1248597C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100415215C (en) * | 2005-11-11 | 2008-09-03 | 江西金海棠药用油有限公司 | Wild camellia seed oil soft capsule |
| CN101120951B (en) * | 2006-08-10 | 2010-05-12 | 孙欣 | Ovarian moisturing soft capsule and preparing process thereof |
| CN102948663A (en) * | 2012-12-19 | 2013-03-06 | 刘书新 | Rana japonica oil granules and preparation method thereof |
| CN103005460A (en) * | 2012-12-04 | 2013-04-03 | 吉林博大农林生物科技有限公司 | Anti-aging rana japonica oil food |
| CN105596424A (en) * | 2016-02-04 | 2016-05-25 | 张菊明 | Rana temporaria chensinensis and mulberry capsule for relieving stress, balancing and nourishing and preparation method thereof |
-
2001
- 2001-12-21 CN CNB011388641A patent/CN1248597C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100415215C (en) * | 2005-11-11 | 2008-09-03 | 江西金海棠药用油有限公司 | Wild camellia seed oil soft capsule |
| CN101120951B (en) * | 2006-08-10 | 2010-05-12 | 孙欣 | Ovarian moisturing soft capsule and preparing process thereof |
| CN103005460A (en) * | 2012-12-04 | 2013-04-03 | 吉林博大农林生物科技有限公司 | Anti-aging rana japonica oil food |
| CN102948663A (en) * | 2012-12-19 | 2013-03-06 | 刘书新 | Rana japonica oil granules and preparation method thereof |
| CN105596424A (en) * | 2016-02-04 | 2016-05-25 | 张菊明 | Rana temporaria chensinensis and mulberry capsule for relieving stress, balancing and nourishing and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1248597C (en) | 2006-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101373636B1 (en) | Composition for improving condition of skin and scalp containing fermented extracts of herb mixture | |
| CN102078283A (en) | Traditional Chinese medicinal nutritional emulsifiable paste for whitening skin and removing speckles | |
| CN104825347B (en) | A kind of medical bio whitening and spot-eliminating dressing and preparation method thereof | |
| CN103432063B (en) | Essence used for treating whelks and pigmentation spots and whitening | |
| CN103417462B (en) | Facial mask for treating whelk and pigment patch and whitening skin | |
| CN101791285B (en) | Clausenamide composite nanometer emulsion for clearing facial age pigment (lipofuscin) and preparation method thereof | |
| KR101374277B1 (en) | Composition for promoting hair growth containing fermented extracts of herb mixture | |
| CN105267717A (en) | Natural herbaceous-plant soup possessing multiple cosmetic efficacies and application thereof | |
| CN101401779A (en) | Cosmetic composition containing composite plant polyphenol extract and method of preparing the same | |
| CN102960602A (en) | Health-care aloe powder | |
| CN103432064B (en) | Cream used for treating whelks and pigmentation spots and whitening | |
| CN1248597C (en) | Forest frog oil soft capsule | |
| RU2283124C1 (en) | Biologically active preparation based on marine vegetable raw | |
| CN105963674A (en) | Natural cell repairing agent and preparation method thereof | |
| CN105534858A (en) | Plant essence powder, facial mask cream and facial mask powder | |
| CN102008083A (en) | Health food for alleviating physical fatigue and removing chloasma | |
| CN107441340B (en) | Hand and foot chap cream for relieving swelling, pain and itching and nourishing skin and preparation method thereof | |
| CN103932941A (en) | Nutritional element aging resistant skin-care lotion | |
| CN101297705B (en) | Compound Tibet sheep placenta capsule for removing wrinkle and resisting aging | |
| CN106937923A (en) | Lucid ganoderma-pollen skin care health care frost | |
| JP2015050991A (en) | Health supplement | |
| CN102919853A (en) | Rana japonica oil soft capsule | |
| CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof | |
| CN103860430B (en) | A kind of beauty mask and preparation method thereof | |
| CN113876676A (en) | Dendrobium beautifying cream and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Free format text: FORMER OWNER: HARBIN JIANKANGREN SCIENCE AND SCIENCE CO. LTD. Effective date: 20050513 |
|
| C10 | Entry into substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20050513 Address after: No. 36, water source road, Miyun Industrial Development Zone, Beijing Applicant after: Beijing Yishoutang Healthcare Technology Co. Ltd. Address before: 150090 No. 20, Harbin hi tech Development Zone, Nangang District, Heilongjiang, Hengshan Road Applicant before: Harbin Jiankangren Science and Science Co. Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HARBIN RED SUN HEALTH INDUSTRY GROUP CO., LTD. Free format text: FORMER OWNER: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Effective date: 20090612 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090612 Address after: Zip code at Bohai road and Weihai Road, Harbin, China: 150069 Co-patentee after: Yishoutang Health Technology Industry Co. Ltd. Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: No. 36, water source road, Miyun Industrial Development Zone, Beijing, China: 101500 Patentee before: Beijing Yishoutang Healthcare Technology Co. Ltd. |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Passing Examination on Formalities |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Termination of Patent Right |
|
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: YISHOU HALL HEALTH SCIENCE AND TECHNOLOGY INDUSTRY CO., LTD. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20110126 Address after: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Co-patentee before: Yishoutang Health Technology Industry Co. Ltd. Patentee before: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Baoguang Document name: Notification to Pay the Fees |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060405 Termination date: 20171221 |